TDP-43 pathology and functional deficits in wild-type and ALS/FTD mutant cyclin F mouse models

被引:0
|
作者
van Hummel, Annika [1 ]
Sabale, Miheer [1 ]
Przybyla, Magdalena [1 ]
van der Hoven, Julia [1 ]
Chan, Gabriella [1 ]
Feiten, Astrid F. [2 ]
Chung, Roger S. [3 ]
Ittner, Lars M. [1 ]
Ke, Yazi D. [1 ]
机构
[1] Macquarie Univ, Fac Med Hlth & Human Sci, Dementia Res Ctr, Macquarie Med Sch, Sydney, NSW, Australia
[2] Ludwig Maximilians Univ Munchen, Fac Med, Biomed Ctr BMC, Div Metab Biochem, D-81377 Munich, Germany
[3] Macquarie Univ, Fac Med Hlth & Human Sci, Ctr Motor Neuron Dis Res, Macquarie Med Sch, Sydney, NSW, Australia
基金
英国医学研究理事会; 澳大利亚研究理事会;
关键词
amyotrophic lateral sclerosis; cyclin F; frontotemporal dementia; mouse models; TDP-43; ubiquitination; FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; MUTATIONS; GENE; EXPRESSION; ONSET; CCNF; ALS; NEURODEGENERATION; PHOSPHORYLATION;
D O I
10.1111/nan.12902
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aims: Amyotrophic lateral sclerosis (ALS) is characterised by a progressive loss of upper and lower motor neurons leading to muscle weakness and eventually death. Frontotemporal dementia (FTD) presents clinically with significant behavioural decline. Approximately 10% of cases have a known family history, and disease-linked mutations in multiple genes have been identified in FTD and ALS. More recently, ALS and FTD-linked variants have been identified in the CCNF gene, which accounts for an estimated 0.6% to over 3% of familial ALS cases.Methods: In this study, we developed the first mouse models expressing either wild-type (WT) human CCNF or its mutant pathogenic variant S621G to recapitulate key clinical and neuropathological features of ALS and FTD linked to CCNF disease variants. We expressed human CCNF WT or CCNFS621G throughout the murine brain by intracranial delivery of adeno-associated virus (AAV) to achieve widespread delivery via somatic brain transgenesis.Results: These mice developed behavioural abnormalities, similar to the clinical symptoms of FTD patients, as early as 3 months of age, including hyperactivity and disinhibition, which progressively deteriorated to include memory deficits by 8 months of age. Brains of mutant CCNF_S621G mice displayed an accumulation of ubiquitinated proteins with elevated levels of phosphorylated TDP-43 present in both CCNF_WT and mutant CCNF_S621G mice. We also investigated the effects of CCNF expression on interaction targets of CCNF and found elevated levels of insoluble splicing factor proline and glutamine-rich (SFPQ). Furthermore, cytoplasmic TDP-43 inclusions were found in both CCNF_WT and mutant CCNF_S621G mice, recapitulating the key hallmark of FTD/ALS pathology.Conclusions: In summary, CCNF expression in mice reproduces clinical presentations of ALS, including functional deficits and TDP-43 neuropathology with altered CCNF-mediated pathways contributing to the pathology observed.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Restoring functional TDP-43 oligomers in ALS and laminopathic cellular models through baicalein-induced reconfiguration of TDP-43 aggregates
    Chang, Hsiang-Yu
    Wang, I-Fan
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [32] TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy
    Mao, Fei
    Robinson, John L.
    Unger, Travis
    Posavi, Marijan
    Amado, Defne A.
    Elman, Lauren
    Grossman, Murray
    Wolk, David A.
    Lee, Edward B.
    Van Deerlin, Vivianna M.
    Porta, Silvia
    Lee, Virginia M. Y.
    Trojanowski, John Q.
    Chen-Plotkin, Alice S.
    ACTA NEUROPATHOLOGICA, 2021, 142 (04) : 629 - 642
  • [33] Restoring functional TDP-43 oligomers in ALS and laminopathic cellular models through baicalein-induced reconfiguration of TDP-43 aggregates
    Hsiang-Yu Chang
    I-Fan Wang
    Scientific Reports, 14
  • [34] Overexpression of ALS-Associated p.M337V Human TDP-43 in Mice Worsens Disease Features Compared to Wild-type Human TDP-43 Mice
    Janssens, Jonathan
    Wils, Hans
    Kleinberger, Gernot
    Joris, Geert
    Cuijt, Ivy
    Ceuterick-de Groote, Chantal
    Van Broeckhoven, Christine
    Kumar-Singh, Samir
    MOLECULAR NEUROBIOLOGY, 2013, 48 (01) : 22 - 35
  • [35] Disulfide cross-linked multimers of TDP-43 and spinal motoneuron loss in a TDP-43A315T ALS/FTD mouse model
    Bargsted, Leslie
    Medinas, Danilo B.
    Martinez Traub, Francisca
    Rozas, Pablo
    Munoz, Natalia
    Nassif, Melissa
    Jerez, Carolina
    Catenaccio, Alejandra
    Court, Felipe A.
    Hetz, Claudio
    Matus, Soledad
    SCIENTIFIC REPORTS, 2017, 7
  • [36] Overexpression of ALS-Associated p.M337V Human TDP-43 in Mice Worsens Disease Features Compared to Wild-type Human TDP-43 Mice
    Jonathan Janssens
    Hans Wils
    Gernot Kleinberger
    Geert Joris
    Ivy Cuijt
    Chantal Ceuterick-de Groote
    Christine Van Broeckhoven
    Samir Kumar-Singh
    Molecular Neurobiology, 2013, 48 : 22 - 35
  • [37] Disulfide cross-linked multimers of TDP-43 and spinal motoneuron loss in a TDP-43A315T ALS/FTD mouse model
    Leslie Bargsted
    Danilo B. Medinas
    Francisca Martínez Traub
    Pablo Rozas
    Natalia Muñoz
    Melissa Nassif
    Carolina Jerez
    Alejandra Catenaccio
    Felipe A. Court
    Claudio Hetz
    Soledad Matus
    Scientific Reports, 7
  • [38] AIT-101 Improves Functional Deficits in a Human TDP-43 Animal Model of ALS
    Young, Peter R.
    DeDuck, Kristina
    Bedell, Barry J.
    MUSCLE & NERVE, 2023, 68 : S5 - S5
  • [39] Expression of Wild-Type and Mutant Human TDP-43 in Yeast Inhibits TOROID (TORC1 Organized in Inhibited Domain) Formation and Autophagy Proportionally to the Levels of TDP-43 Toxicity
    Park, Sangeun
    Park, Sei-Kyoung
    Liebman, Susan W.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [40] Analyses of the pathogenesis in muscle-specific wild-type TDP-43 transgenic mice
    Yamashita, S.
    Kawakami, K.
    Nishikami, T.
    Tawara, N.
    Maeda, Y.
    Ando, Y.
    NEUROMUSCULAR DISORDERS, 2014, 24 (9-10) : 813 - 813